Picture of Oncopeptides AB logo

ONCO Oncopeptides AB Balance Sheet

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Oncopeptides AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments926840362345173
Net Total Accounts Receivable
Net Total Receivables6.9823.23817.327.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets971895412364203
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment17.238.324.720.4
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets993947439385238
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities16535422585.744.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities19637022991182
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity79757721129456.8
Total Liabilities & Shareholders' Equity993947439385238
Total Common Shares Outstanding